COMPARISON OF GENERAL ANAESTHESIA VERSUS COMBINED SPINAL AND EPIDURAL ANAESTHESIA IN PATIENT UNDERGOING LAPAROSCOPIC SURGERIES IN GYNECOLOGY

Abstract

The choice of anesthesia for laparoscopic surgical procedures, whether they are related to gynecology or not, is of utmost importance in determining patient outcomes, surgical results, postoperative recovery, and overall satisfaction with the procedure. Those techniques encompass the use of general anesthesia (ga) and a combination of spinal and epidural anesthesia (csea). Each of them possesses their own unique strengths and weaknesses. However, very few laparoscopic gynecological techniques have gathered sufficient data to evaluate their effectiveness and safety. The intention of this have a look at is to evaluate the effectiveness of popular anesthesia in opposition to blended spinal and epidural anesthesia throughout laparoscopic gynecological surgeries in the context of hemodynamic balance, postoperative ache, healing time, and headaches suffered.This study implemented a randomized controlled trial design for a hundred and twenty patients who were considering laparoscopic surgeries. The sample population was divided into two groups, one consisting of 60 individuals who were manipulated and the other consisting of 60 individuals who underwent a control group. Determined parameters from the patient's included hemodynamic parameters (coronary heart price, blood stress), postoperative ache scores (using the visual analog scale), recovery time (time to ambulation and discharge), and nurses reported complications (nausea, vomiting, respiration despair). When patients undergo laparoscopic gynecological surgical treatment, csea has been mentioned to be better than traditional anesthesia in terms of maintaining stable blood pressure, managing postoperative pain, and promoting faster recovery. Medical professionals recommend that individuals with comorbidities or a higher risk of experiencing hemodynamic instability should consider using continuous subcutaneous aldosterone antagonist therapy (csea) as a treatment option. Further research with additional sample populations is necessary to delve deeper into the effects and assess the long-term outcomes.